Enopace Biomedical Ltd.
USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).
The verdict
According to USPTO PatentsView, Enopace ranks #35,202 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 4 technology areas.
- #35,202
- of 49,997 US assignees by volume
- 18th percentile
- by Innovation Score (25.8/100)
- 15.6
- avg claims per patent
- +33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R35202 · Foreign Corporation #35,202 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL
- GRANTS-MICRO 7 grants
- MID-PACK #35,202/49,997
- PHOTO-FINISH Engineered Network…
- CPC-NARROW A61N · 4 areas
- INNOV-THIN 25.8/100
- CLAIMS-RICH 15.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-UP +33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Engineered Network Systems, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Enopace’s 25.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Enopace
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- BenedorTSE · near 26
BenedorTSE · near
26 score
- TeraFlex · near 26
TeraFlex · near
26 score
- Ductmate Industries · near 26
Ductmate Industries · near
26 score
- Korea United Pharm · near 26
Korea United Pharm · near
26 score
- Enopace Biomedical · this assignee 26
Enopace Biomedical · this assignee
26 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Enopace's Innovation Score is 25.8/100 (18th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Enopace?
Each dot is one of Enopace’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Enopace’s own 15.6 claims/patent is at or below the 16.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Enopace's grants concentrate
Enopace Biomedical Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2015. By volume, Enopace sits between Engineered Network Systems, LLC and Epix Orthopaedics, Inc..
Enopace's three-year grant acceleration
Enopace Biomedical Ltd. shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Enopace's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Engineered Networ…
Engineered Network Systems, LLC
7 patents
- Engineered Seal P…
Engineered Seal Products, Inc.
7 patents
- Enginuity Communi…
Enginuity Communications Corp.
7 patents
- Englert
Englert, Inc.
7 patents
- Enovix Operations
Enovix Operations Inc.
7 patents
- Ensequence
Ensequence, Inc.
7 patents
- Environ-metal
Environ-Metal, Inc.
7 patents
- Epix Orthopaedics
Epix Orthopaedics, Inc.
7 patents
- Enopace Biomedical ◀
Enopace Biomedical Ltd.
7 patents
What this shows Enopace holds 7 patents at rank #35,232, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Enopace
By rank, the assignees closest to #35,232 in granted patent volume.
- Engineered Network Systems, LLC #35,228 · 7 patents
- Engineered Seal Products, Inc. #35,229 · 7 patents
- Enginuity Communications Corp. #35,230 · 7 patents
- Englert, Inc. #35,231 · 7 patents
- Enovix Operations Inc. #35,233 · 7 patents
- Ensequence, Inc. #35,234 · 7 patents
- Environ-Metal, Inc. #35,235 · 7 patents
- Epix Orthopaedics, Inc. #35,236 · 7 patents
Leaders in A61N (Electrotherapy)
Other assignees with the most granted patents in Enopace's primary technology class.
- Medtronic, Inc. 2,200 in class
- Boston Scientific Neuromodulation Corporation 1,080 in class
- Cardiac Pacemakers, Inc. 1,037 in class
- Pacesetter, Inc. 609 in class
- Zoll Medical Corporation 556 in class
- Koniniklijke Philips N.V. 534 in class
- Cochlear Limited 449 in class
- Varian Medical Systems, Inc. 296 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Enopace, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Enopace ranks #515 of 1,943 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (26 here).
Enopace's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
26 18th percentile higher than 18% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 14.3% |
| 2016 | 1 | 14.3% |
| 2017 | 1 | 14.3% |
| 2020 | 2 | 28.6% |
| 2021 | 1 | 14.3% |
| 2022 | 1 | 14.3% |
Which technologies does Enopace Biomedical Ltd. patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Enopace Biomedical Ltd.'s patent record in context - here's where to go next.
- Enopace Biomedical Ltd.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
- Ranked #35,202 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Enopace Biomedical Ltd. against Engineered Network Systems, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 25.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.